{"id":"W4404480970","doi":"10.1016/s2468-1253(24)00317-0","title":"Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Placebo; Crohn's disease; Double blind; Internal medicine; Surgery; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008261384,0.0005080095,0.001134797,0.00016829,0.0001450043,0.00004844064,0.0008167907,0.0002517616,0.0001135467],"category_scores_gemma":[0.0002519839,0.0003907235,0.0005728647,0.0001325683,0.0004382401,0.00001564514,0.0003964593,0.0004040726,0.00008435119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006548462,"about_ca_system_score_gemma":0.000424133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001916678,"about_ca_topic_score_gemma":0.0004059811,"domain_scores_codex":[0.9954737,0.001309127,0.0009689064,0.00104196,0.0002448004,0.0009614617],"domain_scores_gemma":[0.9978412,0.0001523404,0.0002812637,0.001131322,0.0002130254,0.0003807973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9846454,0.0004478863,0.005274017,0.000102773,0.0007042079,0.0006740813,0.0002260732,0.0002254781,0.002066147,0.0001563325,0.005093744,0.000383912],"study_design_scores_gemma":[0.9807659,0.001827261,0.006525234,0.0001185153,0.0007747003,0.000132702,0.00006503885,0.001759411,0.0008356,0.00009238861,0.006684843,0.0004183479],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986524,0.001171664,0.001086673,0.002161337,0.001682532,0.006976129,0.0001364998,0.00005963838,0.000201547],"genre_scores_gemma":[0.9934161,0.0001980563,0.0001477975,0.001977012,0.0008152513,0.002945096,0.000132979,0.000054067,0.0003136351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006892127,"threshold_uncertainty_score":0.9998544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01728513506448125,"score_gpt":0.2875952542572869,"score_spread":0.2703101191928057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}